|
Volumn 35, Issue 12, 2008, Pages 2239-2243
|
Clinical trial of non-specific immunotherapy using Lentinan in advanced or recurrent gastric cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
LENTINAN;
OXONIC ACID;
S 1 (COMBINATION);
TEGAFUR;
UNCLASSIFIED DRUG;
ARTICLE;
CANCER STAGING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG COMBINATION;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
MULTICENTER STUDY;
PATHOLOGY;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
RECURRENT DISEASE;
STOMACH TUMOR;
SURVIVAL RATE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DRUG COMBINATIONS;
HUMANS;
IMMUNOTHERAPY;
LENTINAN;
NEOPLASM STAGING;
OXONIC ACID;
RECURRENCE;
STOMACH NEOPLASMS;
SURVIVAL RATE;
TEGAFUR;
|
EID: 58749114604
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (0)
|